Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored drug conjugate technology for cancer and other diseases, today announced that the first patient has been dosed in its ...

Tumors trigger T-cell exhaustion through a TSP-1–CD47 signaling pathway. Blocking it can restore immune strength and improve cancer treatment.

Review explores how drug repurposing in oncology can reshape the tumor microenvironment, strengthen immune checkpoint ...

ICIs are safe and effective for HIV-positive NSCLC patients, with no significant differences in survival outcomes compared to HIV-negative patients. The efficacy of immune checkpoint inhibitors was ...

Germline Testing for Men With Prostate Cancer: Navigating an Expanding New World of Genetic Evaluation for Precision Therapy and Precision Management The Oncology Grand Rounds series is designed to ...

Immune Checkpoint Blockade in Cancer Therapy The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are ...

Patients with immune checkpoint inhibitor colitis initially treated with high-dose glucocorticoids had a higher risk for rehospitalization than those treated with biologics, according to a study ...